New Strong Sell Stocks for January 28th

06:05am, Tuesday, 28'th Jan 2025
AGL, ASHTY and CCOZY have been added to the Zacks Rank #5 (Strong Sell) List on January 28, 2024.

New Strong Sell Stocks for January 24th

05:01am, Friday, 24'th Jan 2025
WMS, AGL and EADSY have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2025.

New Strong Sell Stocks for January 21st

07:21am, Tuesday, 21'st Jan 2025
VLVLY, AGL and APOG have been added to the Zacks Rank #5 (Strong Sell) List on January 21, 2025.

New Strong Sell Stocks for January 15th

06:06am, Wednesday, 15'th Jan 2025
SKFRY, AGL and ADRZY have been added to the Zacks Rank #5 (Strong Sell) List on January 15, 2025.

New Strong Sell Stocks for January 10th

06:56am, Friday, 10'th Jan 2025
AGL, AEO and AROC have been added to the Zacks Rank #5 (Strong Sell) List on January 10, 2024.

New Strong Sell Stocks for December 31st

06:51am, Tuesday, 31'st Dec 2024
AGL, AMPH and CR have been added to the Zacks Rank #24 (Strong Sell) List on December 31, 2024.

New Strong Sell Stocks for December 13th

04:16am, Friday, 13'th Dec 2024
AGL, BKGFY and BERY have been added to the Zacks Rank #5 (Strong Sell) List on December 13, 2024.

New Strong Sell Stocks for December 4th

04:35am, Wednesday, 04'th Dec 2024
ATI, ARLP and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 4, 2024.

New Strong Sell Stocks for December 2nd

05:31am, Monday, 02'nd Dec 2024
ATI, ATS and AGL have been added to the Zacks Rank #5 (Strong Sell) List on December 2, 2024.

New Strong Sell Stocks for November 19th

05:00am, Tuesday, 19'th Nov 2024
AGL, AFLYY and BATRK have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2024.

New Strong Sell Stocks for November 13th

07:50am, Wednesday, 13'th Nov 2024
AOS, AGL and ABG have been added to the Zacks Rank #5 (Strong Sell) List on November 13, 2024.
Barclays lowered the firm's price target on Agilon Health to $2 from $5 and keeps an Underweight rating on the shares. The company's Q3 results underscore the lack of visibility into real-time trends
agilon health, inc. (NYSE:AGL ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Office
I initially rated agilon health, inc. as a “hold” due to its volatile financial results and uncertain future, but recent developments necessitate a downgrade to 'sell'. The company's stock plummet
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Stree
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE